---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-005654"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T01:58:10.195124+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# CalciMedica director Eric Bjerkholt resigns; Alan Glicklich appointed to board

## Summary
- Eric Bjerkholt resigned as director and audit committee chair effective Jan 15, 2025; no disagreement with company.
- Board appointed Alan Glicklich, M.D. as Class I director effective same date, term expires at 2027 annual meeting.
- Dr. Glicklich receives $40,000 annual cash retainer (pro-rated) and option for 20,000 shares vesting over three years.
- No arrangements or transactions requiring disclosure under Item 404(a) between Dr. Glicklich and company.

## SEC filing metadata
- accession: 0001193125-25-005654
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/0001193125-25-005654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/d902412d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-005654
- JSON: https://secwatch.observer/filing/0001193125-25-005654.json
- Plain text: https://secwatch.observer/filing/0001193125-25-005654.txt

## Key facts
- Executive change
  Alan Glicklich was appointed as Class I Director at CalciMedica, Inc..
  - Action: appointed
  - Role: Class I Director
  source text: On January 13, 2025, the Company’s Board appointed Alan Glicklich, M.D., as a Class I director of the Company, effective as of the Effective Date, with a term of office expiring at the 2027 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/0001193125-25-005654-index.htm
- Executive change
  Eric Bjerkholt resigned as Director and Chair of Audit Committee at CalciMedica, Inc..
  - Action: resigned
  - Role: Director and Chair of Audit Committee
  source text: On January 10, 2025, Eric Bjerkholt tendered his resignation as a member of the board of directors (the “Board”) of CalciMedica, Inc., a Delaware corporation (the “Company”) and as Chair and a member of the audit committee of the Board, effective as of January 15, 2025 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/0001193125-25-005654-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.